<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0002">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Lai</surname>
    <given-names>CL</given-names>
   </name>, 
   <name name-style="western">
    <surname>Rosmawati</surname>
    <given-names>M</given-names>
   </name>, 
   <name name-style="western">
    <surname>Lao</surname>
    <given-names>J</given-names>
   </name>, 
   <name name-style="western">
    <surname>Van Vlierberghe</surname>
    <given-names>H</given-names>
   </name>, 
   <name name-style="western">
    <surname>Anderson</surname>
    <given-names>FH</given-names>
   </name>, 
   <name name-style="western">
    <surname>Thomas</surname>
    <given-names>N</given-names>
   </name>, 
   <name name-style="western">
    <surname>Dehertogh</surname>
    <given-names>D</given-names>
   </name>
  </person-group>
  <year>2002</year>
  <article-title>Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection</article-title>. 
  <source>Gastroenterology</source>. 
  <volume>123</volume>(
  <issue>6</issue>):
  <fpage>1831</fpage>â€“
  <lpage>1838</lpage>.
  <pub-id pub-id-type="pmid">12454840</pub-id>
 </mixed-citation>
</ref>
